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marrow vasculature
David Stegner 1, Judith M.M. van Eeuwijk1, Oğuzhan Angay2, Maximilian G. Gorelashvili1, Daniela Semeniak1,
Jürgen Pinnecker2, Patrick Schmithausen2, Imke Meyer3, Mike Friedrich2, Sebastian Dütting1, Christian Brede4,
Andreas Beilhack4, Harald Schulze 1,3, Bernhard Nieswandt1,2 & Katrin G. Heinze2
In mammals, megakaryocytes (MKs) in the bone marrow (BM) produce blood platelets,
required for hemostasis and thrombosis. MKs originate from hematopoietic stem cells and
are thought to migrate from an endosteal niche towards the vascular sinusoids during their
maturation. Through imaging of MKs in the intact BM, here we show that MKs can be found
within the entire BM, without a bias towards bone-distant regions. By combining in vivo two-
photon microscopy and in situ light-sheet ﬂuorescence microscopy with computational
simulations, we reveal surprisingly slow MK migration, limited intervascular space, and a
vessel-biased MK pool. These data challenge the current thrombopoiesis model of MK
migration and support a modiﬁed model, where MKs at sinusoids are replenished by sinu-
soidal precursors rather than cells from a distant periostic niche. As MKs do not need to
migrate to reach the vessel, therapies to increase MK numbers might be sufﬁcient to raise
platelet counts.
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P latelets play key roles in hemostasis and thrombosis and arethe second most abundant cell type in the blood. Due totheir short life span of only a few days, anuclear platelets
are continuously replenished and thus provide a classic system
to study hematopoiesis. The hematopoietic growth factor
thrombopoietin (TPO) is the major cytokine triggering platelet
production. TPO supports the self-renewal of hematopoietic stem
cells (HSCs) and also induces transcription factors leading to the
expression of proteins like CD42 (GPIb-V-IX complex) or CD41
(GPIIb) that commit HSCs to the platelet lineage1, 2. These
committed precursor cells, designated megakaryocytes (MKs),
then increase markedly in size and become polyploid. During
their ﬁnal maturation under the transcription factor NF-E2,
MKs express the MK/platelet-speciﬁc tubulin isoform β13, 4.
Cytoplasmic MK-extensions called proplatelets pass
through the endothelial barrier at bone marrow (BM) sinusoids—
as recently suggested5—within the lungs, and are shed into the
circulation. Each MK releases hundreds of virtually identical-
sized platelets into the blood vessel2, 6. Under inﬂammatory
conditions or acute platelet demand, platelet release also occurs
via rupture of the mature MK membrane7. In both cases (pro-
platelet formation and MK rupture), MKs must reside next to the
vessel to release platelets into the bloodstream. According to the
current model of megakaryopoiesis, blood cell precursors migrate
from an endosteal niche towards the vessel sinusoids during
maturation1, 8–11. This concept is primarily based on qualitative
and quantitative evaluation of distinct progenitor cell populations
present at distinct spatiotemporal niches. A seminal paper by
Avecilla et al. has demonstrated that, while mice lacking TPO or
its receptor c-Mpl have severely reduced platelet counts,
the systemic application of the chemokines stromal cell-derived
factor-1 (SDF1, CXCL-12) together with ﬁbroblast growth
factor 4 (FGF4) can transiently restore the number of peripheral
platelets by directing MKs towards BM sinusoids1, 8. Interestingly,
in contrast to the MK maturation model, Junt and colleagues
observed by intravital two-photon microscopy (2P-IVM) that
MKs barely migrate and are mostly found in close proximity
to blood vessels6. Unfortunately, this previous study has assessed
only a relatively small number of MKs, as the ﬁeld of view in
2P-IVM is limited and due to the CD41-YFP reporter mice used.
In these mice only one third of MKs become ﬂuorescently labeled
due to unexplained reduced penetrance of the transgene, while
the CD41/61 (GPIIb/IIIa) expression is reduced, due to the
heterozygous CD41-knockout in these animals6, 12. Thus, the
authors mostly used TPO-treated mice to enhance the number of
visible cells. So far, the discrepancy between the current model of
megakaryopoiesis and the in vivo data shown by Junt et al. has
not been reconciled.
As a result of recent developments in imaging techniques,
we were able to analyze the distribution of MKs within the bone
marrow by combining different in vitro and in vivo imaging
techniques with computational simulations. We provide
independent lines of evidence that challenge the directed MK
migration model and provide a modiﬁed model, where MKs
at sinusoids are replenished by precursors originating from a
sinusoidal niche rather than from a periostic niche.
Results
Most MKs are residing directly at the vessels. We performed
in vivo antibody labeling targeting the MK-speciﬁc and
platelet-speciﬁc von Willebrand factor receptor subunit GPIX
(CD42a) to overcome the limitations of the CD41-YFP mouse
and to stain the entire MK population in the mouse BM, without
affecting platelet production (Supplementary Figs 1A–D).
This labeling scheme also obviated the necessity for
TPO-treatment to increase the number of labeled MKs. Since
platelets are continuously produced, we analyzed MK migration
under steady-state conditions, visualizing the BM in the mouse
skull using 2P-IVM. We tracked single MKs (n= 54) over time at
a frame rate of 1f/min and discovered that the cells were sessile
(Fig. 1a–c, Supplementary Movie 1). MKs had an instantaneous
velocity of 0.38± 0.47 µm/min (median± SD) and displayed
either just a wobbling or shifted their center of mass during
proplatelet formation at BM sinusoids, in line with previous
reports6. We then assessed MK mobility by analyzing MK tracks
based on an anomalous diffusion model. The mean squared
displacement (MSD=< r2(t)>= 4 Kαtα) of MKs was calculated
for different time scales t as the MSD can be directly linked to
(the time scale-dependent) diffusion coefﬁcient Kα and the
anomalous diffusion exponent α. For MK migration, we found
low values (median± SD) for the MSD (0.35± 0.41 µm2) and α
(0.65± 0.22), indicating a slow, subdiffusion-like movement in a
highly crowded environment (Fig. 1c), further demonstrating
hindered movement of MKs in the BM.
As most studies of murine hematopoiesis have been performed
on long bones and 2P-IVM approach in the cranial BM has a
limited ﬁeld of view, we next performed immunohistochemical
analysis of cryo-sections13 of murine femora (Fig. 2a) and sterna
(Fig. 2b). Under steady-state conditions, we found no regions
lacking cells of the megakaryocytic lineage (CD41-positive).
Surprisingly, MKs were not only found near the sinusoids
(labeled with anti-CD105 or anti-CD31 antibodies), but also in



























Fig. 1MK tracking reveals low motility of MKs in vivo. a A representative centroid track (magenta) from a MK (green, scale bar 15 µm) monitored for over 3
h. Frame rate: 1 f/min b Trajectories of individual MKs (n= 54 from six different mice) over a time period of 3 h; individual trajectories of MKs are
represented by different blue (vessel-associated, n= 46) and red (non-vessel associated, n= 8) shadings. Frame rate: 1 f/min c MSD analysis of individual
MKs (n= 54) for different time scales. Corresponding α coefﬁcients can be derived from slopes in the log-log-plot; MSD curves of individual MKs are
represented by different blue (vessel-associated, n= 46) and red (non-vessel associated, n= 8) shadings
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close contact to endosteal zones (indicated by dark regions
surrounding the BM, Fig. 2a, b). MK diameters were comparable
in sternum and femur (22.19± 0.14 µm vs. 22.57± 1.44 µm) and
in both, the majority of MKs (68.2± 6.9% vs. 73.1± 5.2%) was
found in direct contact with the vessel (distance < 2 µm), which
is in agreement with previous studies6, 14. Of note, consecutive
cryo-sections conﬁrmed that more than 99% of CD41-positive
MKs were also positive for GPIX (CD42a) (Supplementary
Fig. 1A). Both groups also showed identical MK diameters
and percentage of vessel association. We next examined the
localization of the MK-speciﬁc tubulin isoform β1 as a marker for
mature MKs4 (Fig. 2c). As expected, mature β1-positive MKs
were larger than immature β1-negative CD41-positive cells
(23.53± 6.23 µm vs. 20.19± 4.24 µm, Fig. 2d). Surprisingly,
however, maturation was not accompanied by altered MK
distribution, as the majority of both β1-tubulin negative and
positive cells were in direct contact with the vessel (66.9± 4.5
vs. 73.9± 4.9%; Fig. 2e). In addition, vessel-MK distances of
non-vessel associated (NVA) MKs were indistinguishable for
β1-tubulin negative and positive cells (Fig. 2f). Next, we assessed
the percentage of β1-tubulin positive CD41-positive cells within
100 µm distance from the bone cortex, compared to more distant
MKs. Interestingly, the percentage of β1-tubulin positive cells
among all MKs was identical between the ‘bone-associated’ and
more distant MK population (83.0± 2.8% vs. 82.7± 2.6%;
Fig. 2g). Thus, the majority of MKs was found in close proximity
to the sinusoids, independently of their size or maturation state.
MKs are distributed throughout the BM. To assess the MK
distribution in its intact 3D environment, we utilized light-sheet
ﬂuorescence microscopy (LSFM) to examine complete and intact
bones (Supplementary Movie 2, Supplementary Fig. 2A, B).
We ﬁrst established a clearing protocol, leading to optically
transparent bones (Supplementary Fig. 2C, D)15–18. To avoid
staining artifacts due to insufﬁcient antibody penetration in situ,
we performed in vivo labeling using an anti-GPIX antibody
derivative19, 20. LSFM transversal imaging of the cleared and
intact femora and sterna allowed visualization of MKs with a
resolution of less than 2 µm, which was sufﬁcient to identify
proplatelets extended by MKs (Supplementary Fig. 2B,
Supplementary Movie 3 and 4). 3D reconstructions of LSFM data
revealed a surprisingly dense blood vessel network with an
average vessel-to-vessel distance of only 43.18± 12.72 µm in the
sternum (Fig. 3a). The mean MK diameter was determined as
20.36± 8.19 µm (Fig. 3a), comparable to the values obtained with
cryo-sections. Thus, the spatial distribution of MKs is highly
restricted by the vasculature as the vessel-to-vessel distance
equals the diameter of two MKs. In line with this, we found that
























































































Fig. 2 MKs are largely sessile and distributed within the BM. Distribution of megakaryocytes (MKs, CD41+, green) in cryo-sections of femur a and
sternum b showing vessels (CD105+, red) and nuclei (Hoechst33258, blue, Scale bar: 1 mm (left panels), 100 µm (right panels). c MKs were counter-stained
for β1-tubulin (magenta, indicated with arrowheads—in contrast to β1− MKs which are indicated with arrows); scale bar 20 µm. These mature MKs were
larger d, but distributed similarly as depicted by the percentage of vessel-associated MKs e and the distance to vessels of non-vessel associated (NVA)
MKs f. g The percentage of β1-tubulin positive CD41-cells within 100 µm distance from the bone cortex (BA bone-associated) and more distant MKs
(NBA non-bone associated) was similar. Bar graphs represent mean± SD; n= 4. **p< 0.01. There are no signiﬁcant differences in e–g (p> 0.05;
Mann–Whitney U test)
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(Fig. 3b). This value is higher than those obtained by analyzing
cryo-sections, likely due to vessels which are missed as they are
located above or beneath the analyzed plane of the bone section.
Analyzing the 3D LSFM data sets by virtual slicing revealed
that the 3D information signiﬁcantly improves quantitative cell
analysis, as it reduces the risk of overrating cell distances due to
‘off-center’ cell slicing and other well-known cutting artifacts.
Equally important, LSFM enabled us to analyze 30-fold more
MKs per bone sample compared to conventional sections.
Thus, we can demonstrate that within an entire bone the pool of
MKs is distributed throughout the microvessel network. Analysis
of ﬁve equally sized sub-stacks of the complete 3D stack of an
intact bone revealed identical values in all MK parameters
(Fig. 3c), further supporting the hypothesis that the entire BM
contains MKs.
Next, we assessed whether the BM is structured differently
between different types of bone. To this end, we conﬁrmed that
the bone-like structures at the outer linings of femur or sternum
sections are positive for collagen I21 (Supplementary Fig. 3A), and
partly positive for osteocalcin (Supplementary Fig. 3B). We noted
that in our LSFM data these structures displayed a characteristic
auto-ﬂuorescence signal (Supplementary Fig. 3C), enabling
segmentation of bone structures from our LSFM data (Fig. 4a,
Supplementary Fig. 4A, B). We determined the bone-to-bone and
vessel-to-vessel distances of femur diaphysis (Supplementary
Movie 5), femur epiphysis (Supplementary Movies 6 and 7),
sternum (Supplementary Movie 8), and cranial BM (Supplemen-
tary Movie 9). Of note, while bone-to-bone distances differed
between femur diaphysis and the other three types of bone
(Fig. 4b), vessel-to-vessel vessel, as well as MK-to-vessel distances
were indistinguishable (Fig. 4c). Consequently, the majority of
MKs was vessel-associated in all four types of BM (Fig. 4d).
As the ‘classical concept’ of megakaryopoiesis suggests a
migration from the bone associated (BA) endosteal niche
towards the vasculature during MK maturation, we compared
bone-associated; less than 100 µm distance from the bone cortex)
and non-bone-associated (NBA) MKs (Fig. 4e) in femur diaphysis
(Fig. 4f) and sternum (Fig. 4g). Notably, in either case BA
and NBA MK parameters were indistinguishable (Fig. 4f, g),
corroborating our ﬁnding that we could not detect any
MK-deﬁcient areas within the BM.
Platelet depletion does not affect megakaryocyte motility.
Having established assays for MK motility and 3D distribution,
we next tested the effects of increased platelet consumption. We
depleted platelets using anti-GPIbα antibodies that cause rapid
Fc-independent platelet clearance19. This antibody treatment
resulted in severe thrombocytopenia (virtually no circulating
platelets on d1; 10.4± 8.7% of the respective unaffected values on
d3, restored platelet counts on d7, Fig. 5a). Based on the kinetics
of the platelet turnover, we analyzed the BM on d3.5 post
application 2P-IVM, a time point at which replenishing platelet
production was expected to have reached its maximum.
Interestingly, despite the severe thrombocytopenia, we found no
evidence for any MK migration under these conditions, even
for observation periods of several hours. MKs displayed an
instantaneous velocity of 0.02± 0.06 µm/s (median± SD) and
MK tracks (Fig. 5b, c, Supplementary Movie 10) resembled
those of steady-state conditions (Fig. 1b). Likewise, MSD values
(0.40± 0.39 µm2) and α values (0.45± 0.18) were low, indicating
that despite increased platelet turnover, MKs still displayed a slow
and subdiffusion-like movement in a highly crowded
environment.
To expand our observations to a larger ﬁeld of view, we
performed LSFM analyses of sterna at multiple time points post
platelet depletion. Notably, we did not detect any signs of MK loss
due to rupture and the main MK parameters remained grossly
unaltered. We did observe a mild increase in total MK volume at
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Fig. 3 The intervascular space limits MK distribution within the BM. a Reconstruction of sternal BM revealed a dense blood vessel network (red, CD105)
with limited space for MKs (green, GPIX) shown by vessel-to-vessel distances and average MK diameter (n= 5 mice). Cyan dots represent the center
(maximal distance) between two adjacent vessels. Scale bar 50 µm. b Most MKs are localized adjacent to sternal sinusoids and c MK diameters and MK
distribution, shown by the percentage of vessel associated MKs, were comparable throughout the whole sternum in ﬁve different sections of the
reconstructed BM. Bar graphs represent mean± SD; n= 5; grid square= 100 µm. There are no signiﬁcant differences in c (p> 0.05; Mann–Whitney U test)
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vessel-associated MKs as the “vessel-distant” space is smaller
for bigger cells (Fig. 5d–f). The LSFM-data of the platelet-
depleted mice indicate that even upon high platelet demand,
the MK distribution remains overall unaltered, which stands in
clear contrast to the idea that immature MKs migrate toward
vessels.
Next, we assessed the DNA replication rate in vessel-associated
and vessel-distant MKs as a readout for MK (endo-)replicatory
activity. We used the nucleotide derivative 5-ethynyl-2’-deoxyur-
idine (EdU) that becomes incorporated into DNA of proliferating
cells during DNA replication with a limited toxicity22, 23.
In contrast to in situ DNA stainings, EdU labeling provides
‘temporal’ information, as it labels only DNA which had been
synthetized in the presence of EdU. Maturing MKs undergo
endoreplication, which would result in highly EdU-labeled
cells. Mice were fed daily with EdU for 10 days in order to
obtain levels with sufﬁcient bioavailability for cellular
uptake, DNA incorporation and reliable detection afterwards
(Supplementary Fig. 5). Following platelet depletion or control
antibody injection, EdU feeding was continued and sectioned
bones were stained at the indicated time points to assess the
amount of EdU incorporation into MKs (Fig. 5g). As MKs have a
range of ploidy grades and can undergo further rounds of
endoreplication, they are expected to have achieved incorporation
of the trackable nucleotide, depending on the MK ploidy level at
start and the number of endoreplication cycles undergone in
sufﬁcient bioavailability. We classiﬁed MKs into the three
categories: “no”, “weak”, and “strong”, based on the staining
intensity in the nucleus. As expected, the staining intensity
increased over time (Fig. 5g). Notably, highly EdU-positive
MKs were predominantly found in close proximity to the
vasculature indicating that MK endoreplication occurs mostly
directly at sinusoids. In mice treated with the depletion antibody,
we found more EdU positive MKs on day 3 as compared to
control animals, reﬂecting that the MK endoreplication rate
was increased due to elevated platelet demand. However, at
later time points the system ‘bounced back’ to ‘normal’ as the
fraction of EdU-negative (= non-DNA replicating MKs) was
similar between platelet-depleted and unchallenged mice on day 5
and 7 (Fig. 5g). Likewise, the fraction of strongly stained MK
fraction was comparable between the two groups. These results


































































































































































































Femur diaphysis Sternum Skull
Skull Epi. SternumDia. Skull Epi. SternumDia. Skull
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Fig. 4 The inter-bone space is fully vascularized and contains MKs. a Reconstruction of BM along with bone structures for different types of bone revealed
that the entire BM contains MKs (green, GPIX) and blood vessels (red, CD105). Grid square= 200 µm. b Quantitative analyses revealed that bone-to-bone
distances differ between femur diaphysis (dia.) on the one hand and femur epiphysis (epi.), sternum, skull on the other hand. However, the vessel-to-vessel
distances c and the percentage of vessel associated MKs d are comparable. MKs were grouped in bone associated (BA) or non-bone associated (NBA,
more than 100 µm distance from the bone cortex) as depicted schematically e. A subsequent analysis of MK parameters for femur f or sternum g revealed
that the percentage of vessel-associated MKs, the MK distance to the vessel of non-vessel-associated MKs or MK diameters were similar between BA and
NBA MKs in both types of bone. Bar graphs represent mean± SD; n= 4; ***p< 0.001 (Mann–Whitney U test)
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thrombopoiesis even under conditions of high platelet
production.
Short-term CXCR4 inhibition does not affect MK distribution.
The chemokine receptor CXCR4 has been shown to modulate
MK transmigration through an endothelial layer in vitro24–26 and
its ligand SDF1 induces MK migration in vitro27. CXCR4 also
contributes to platelet production, especially in the absence of the
TPO-c-Mpl axis8. Therefore, we blocked CXCR4 in wild type
mice using Plerixafor (AMD3100) and determined the effects on
MK localization after 24 h. Treatment with Plerixafor resulted in
elevated HSC counts (Sca-1+, c-kit+, Lin− cells) in the peripheral
blood after 24 h (290± 56% of control counts), conﬁrming
previous results28. Platelet counts were slightly decreased 1 h after
the treatment (768± 72 vs. 977± 56 platelets/nl blood), but
indistinguishable from those of control mice after 24 h (987± 185
platelets/nl blood). However, CXCR4 blockade did not modulate
MK localization or volume (Fig. 6a–c). Similar results were
obtained in mice receiving the CXCR4 ligand SDF1 24 h before
analysis (Fig. 6a–c), indicating that, despite the relevance of the
SDF1-CXCR4 axis for HSC mobilization29, it appears to be
negligible for MK (re)localization.
Integrin signaling is a central step in mediating cell adhesion
and migration30, 31. Talin1 is a critical mediator of integrin
activation and outside-in signaling32, 33. Consequently, we
assumed that talin1-deﬁciency could affect MK migration
and result in altered MK localization, despite the fact that
MK/platelet-speciﬁc talin-deﬁcient mice (Tlnﬂ/ﬂ, Pf4-Cre) have
unaltered platelet counts32. To assess this directly, BM sections of
Tlnﬂ/ﬂ, Pf4-Cre mice32 were assessed (Fig. 6d). Surprisingly, the
percentage of vessel associated MKs (Fig. 6e) and the MK-vessel
distance of the NVA MKs (Fig. 6f) were indistinguishable
between talin-deﬁcient animals and littermate controls. These
data indicate that classical integrin-dependent cell migration is
not required during megakaryopoiesis.
Simulations imply a vessel-biased MK distribution. The high
numbers of MK and their limited migratory capacity led us to
hypothesize that MKs are randomly distributed throughout
the BM. To test this hypothesis, we made use of computer
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Fig. 5 Platelet depletion does not affect MK distribution or migration within the BM. a Mice displayed severe, but reversible thrombocytopenia after
platelets were depleted by anti-GPIbα antibodies (ﬁve mice per group). b Trajectories of individual MKs in cranial BM on d3.5 after platelet depletion; each
color represents one MK track. c A representative MK that remained sessile for 2.5 h before starting to form proplatelets in a vessel (dashed line) (see also
Supplementary Movie 10; scale bar 20 µm). d–f Sterna were analyzed by LSFM on day 1, 3, 5, and 7 following platelet depletion (ﬁve mice per day). Bar
graphs represent mean± SD. Increase in vessel associated MKs upon platelet depletion d correlates with an increase in MK-volume of vessel associated
(gray bars, e) but not of non-vessel associated MKs (black bars, e). f Total MK numbers remain unaltered. Bar graphs represent mean± SD. *p< 0.05, **p
< 0.01 (Mann–Whitney U test). There are no signiﬁcant differences in e or f (p> 0.05; one-way ANOVA). g DNA synthesis rate in MKs in vivo after
platelet depletion (ﬁve mice per day). Femur bones were sectioned and stained for EdU (red), which is incorporated into nuclei (blue). MKs are stained with
anti-CD41 antibody (green). EdU incorporation was detected in vessel-associated (vessel) and non-vessel-associated (non-v.) MKs at the indicated time
points in platelet depleted (plt-depl) and control injected mice
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3D environment. For modeling, the morphology and size of the
MKs, as well as the BM vasculature, were derived from isosurfaces
of experimental data, thus accurately reﬂecting the physiological
situation spatially. The MK-like objects were randomly placed
into the BM, however a fully random MK distribution (SimR) did
not reﬂect the distribution from our 3D imaging results (Fig. 7a).
The MK population in vivo is not randomly distributed,
but displays a vessel-biased distribution (Fig. 7a). The SimR
simulation predicts signiﬁcantly larger MK-vessel distances and
a lower percentage of vessel-associated MKs (62.8± 1.9%
compared to 70.1% in experimental data). Next, in a modiﬁed
simulation, we only considered the MK subpopulation of the
NVA MKs (SimVA, dark green in Fig. 7b) to be random. To this






































































































Fig. 6 CXCR4-blockade or talin-deﬁciency does not affect MK distribution within the BM. Treatment with 5mg/kg bodyweight AMD3100 (AMD) or 16
µg/kg bodyweight SDF1 did not modify MK localization a, volume b or numbers (four mice per group) (c). d, e Talin-deﬁciency (Tln−/−) did not affect MK
distribution (Scale bar 50 µm) or MK to vessel distances of non-vessel associated (NVA) MKs (f) (n= 5 for Tln−/−, n= 4 for WT). Bar graphs represent
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Fig. 7 MKs display a vessel-biased random distribution. MK distribution was simulated (n= 6 simulations) using blood vessels (red) and MKs (green)
derived from sternal BM imaging data. a The average distance of random distributed MKs to the vessel (SimR) is increased compared to actual data.
***p< 0.001. b Simulated vessel-associated MKs are depicted in light green, non-vessel-associated MKs are depicted in dark green. c Random simulation of
only the non-vessel associated MK population results in average distances comparable to those obtained by 3D imaging data. d According to the current
model of megakaryopoiesis (left panel), blood cell precursors migrate from the endosteal niche towards the vessel sinusoids during maturation. Our data
support a revised model (right panel) where MKs reside directly at the sinusoids and are replenished by precursors originating from the sinusoidal niche
rather than a periostic niche
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as a space restricting scaffold and 30% of the MKs were randomly
seeded into the remaining intervascular region. Under these
conditions, the model fully matched the distribution of NVA
MKs from the 3D imaging data (Fig. 7c) and validates our
previous conclusion that MKs do not migrate within the BM:
If migration was required to reach the vessel, “free” (NVA) MKs
would show an increasing density gradient towards the vessels.
In contrast, our results emphasize a random distribution of both
immature and mature “free” MKs throughout the BM. Thus, the
computer simulation data and the statistical analysis of MK-vessel
distances in the whole intact bone suggest that the majority of
MKs reside directly at the vasculature (Fig. 7d), indicating that
they are replenished by progenitors in close spatial proximity.
Discussion
Our whole-organ imaging approach revealed that the entire
inter-bone space is ﬁlled with BM that is fully vascularized,
leaving no space for vessel-distant-niches. The combination
of our experimental and modeled data strongly requests and
supports a revised model of megakaryopoiesis, with the majority
of MKs residing directly at the sinusoids (Fig. 7d), independently
of their distance to the bone cortex (Fig. 4). Thus, vasculature
seems to dictate the distribution of the vast majority of MKs,
namely those in direct contact to the vessels. In contrast, NVA
MKs are randomly distributed across the BM with negligible
mobility. Moreover, there are no differences in the distribution of
‘young’ and mature MKs (Fig. 2g). This clearly contradicts the
current idea of cellular migration during megakaryopoiesis.
Notably, the current model is based primarily on the seminal
paper of Avecilla et al., who revealed that a co-injection of SDF1
and FGF4 into c-MPL-deﬁcient mice transiently increases
platelet counts8. The increased MK numbers at the sinusoids after
SDF1-injection have been interpreted as result of MK migration
towards the vessel. However, an increase of MK numbers—due to
accelerated HSC differentiation—would inevitably result in an
increase of MKs with vessel contact, even if the relative MK
distribution remained unaltered. As HSCs and other progenitor
cells are also affected by the CXCR4–SDF1 axis34, it is possible
that this initial study8, which used relatively long observation
periods after SDF1 treatment, was confounded by effects acting
rather indirectly on the spatiotemporal MK distribution.
The current model of MK migration is also supported by
in vitro data24, 26, 27. However, two of these in vitro studies
assessed MK transmigration through an endothelial layer24, 26.
Thus, CXCR4 might be critical to facilitate the last step of MKs
and to some extent polarize them, so that they adhere to the
endothelial layer (as it has been described in vitro by24) before
they start forming proplatelets. However, to the best of our
knowledge, WHIM syndrome (warts, hypogammaglobulinemia,
infections, and myelokathexis syndrome), which is at least in
some patients caused by hyperreactive CXCR4 signaling35 is not
associated with altered platelet counts. Thus, it may as well
be that CXCR4 signaling is not required for thrombopoiesis.
Mazharian et al. assessed MK migration using cell tracking and
visualizing cell movement in vitro, albeit in the absence of BM
environment27. They revealed that SDF1-triggered MK migration
depends on the Src-Syk-PLCγ2 axis. However, platelet counts are
not affected by MK and platelet speciﬁc Syk-deﬁciency36. Of note,
deﬁciency of talin1 or kindlin-3, both critical mediators of
integrin activation and cell migration, did not affect platelet
counts either32, 37. More importantly, we did not observe any
effects of talin-deﬁciency on MK distribution (Fig. 6). Likewise,
leukocyte adhesion deﬁciency, type III patients, who have loss-of-
function mutations in FERMT3 (the gene encoding for kindlin-3)
do not suffer from thrombocytopenia. Independently of the
relevance of SDF1-CXCR4 signaling in vitro, our study clearly
demonstrates that MKs do not need to migrate to the vessel due
to the low vessel-to-vessel distances. One reason appears to be the
dense BM vasculature restricting the extraluminal space in vivo,
thereby precluding the need for MK migration, as growing
MKs will reach a vessel with minimal movement. In addition, our
2P-IVM data, with up to 4-h long recordings, show that MKs
barely move. The vessel-associated localization of MKs enables a
rapid response under conditions of increased platelet need. After
platelet depletion we did not observe MK rupture, indicating that
only under inﬂammatory conditions7 platelet generation may
occur without proplatelet formation. Interestingly, platelet
depletion did neither affect MK migration (Fig. 5b, c) nor the
MK distribution in the BM (Fig. 5d–f). Such overall unaltered
MK distribution, even under conditions of elevated platelet
production, provides indirect evidence for the existence of a key
regulatory mechanism that places the origin of the vast majority
of MKs in closest vicinity to the vessels. In support of this, we
observed a similar distribution of ‘young’ (β1-tubulin negative)
vs. mature MKs (Fig. 2g). This allows platelet counts to recover
quickly after depletion. Even if the exact mechanism remains to
be elucidated, the ﬁndings here unveil that it is crucial to pay
particular attention to the vascular niche when it comes to the
origin of MKs. In contrast, the ‘real’ endosteal zone, which lacks
vascularization, is restricted to the outer part of the bone and
basically cell-free (Figs. 2 and 4, Supplementary Fig. 3). When
assessing MK distribution close to these ‘outer’ zones, we did not
observe any differences compared to the MK distribution in the
‘inner’, clearly not endosteal, region (Figs. 2 and 4). Thus, we have
not depicted the endosteal niche in our revised model (Fig. 7d).
Our data rather support the concept of functional endosteal
and vascular niches within the BM which are not completely
separable38. This is in agreement with previous studies indicating
perivascular ‘niches’ for HSCs within the BM39–41, and is further
supported by a recent report demonstrating that non-dividing
stem cells mainly localize at a perisinusoidal site42.
Besides their ‘classical’ niche within the BM, murine MKs can
also be found in the spleen. Platelet production has also been
described within the capillary beds of the lungs5, 43, 44. However,
after analyzing more than 230 MKs in total and more than 24 h of
2P-IVM video recordings we observed almost no MKs within the
BM vasculature (0.87% of MKs). Using LSFM, which allowed
analysis of high sample numbers, MKs were rarely found within
the vasculature (2.0± 1.6% of all MKs). Thus, it appears unlikely
that the translocation of BM-derived mature MKs into different
organs would be a dominant phenomenon.
A vessel-biased MK distribution is critical to enable efﬁcient
proplatelet formation upon demand. However, this MK
distribution appears to be the consequence of the dense
microvasculature and presumably perisinusoidal HSCs42.
Consequently, it appears likely that MK precursor cells reside in
close proximity to the vasculature, allowing the rapid generation
of new MKs upon platelet demand (Fig. 3). In addition, the
vessel-biased distribution of MKs could be supported by MK
polarization (e.g., via ‘directed growth’). Polarization may be
triggered by mechanical cues, such as adhesion to endothelial
cells expressing vascular cell-adhesion molecule-18 or by
environmental soluble factors such as SDF1 or sphingosine-1-
phosphate8, 14. With that in mind, MK positioning could affect
platelet production rather than megakaryopoiesis. However, we
cannot rule out the possibility that two pools of MKs exist: one
pool that resides directly at the vessel to readily produce platelets
(e.g., on demand), whereas a second, largely quiescent pool of
MKs or (potentially) megakaryocytic progenitor cells, resides
more distant from the vasculature. The hypothesis of two rather
distinct MK pools is supported by our EdU-experiment (Fig. 5g).
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This experiment allows to distinguish between two models:
A ‘serial tube’ model where all mature MKs are used for platelet
release before new precursors differentiate and take up EdU (ﬁrst
in-ﬁrst out, all mature MKs would be EdU-positive) or a ‘dual
MK pool’ model in which mature EdU-negative MKs are still
present. In fact, our results show a substantial fraction of MKs to
be EdU-negative (even for an extended EdU-feeding period and
increased platelet demand) so that the ‘dual MK pool’ model is
the more likely one. A similar concept has been proposed for
HSCs40, 45, which reside either directly at the blood vessels or at
the endosteal niche39–42. The combination of previous reports on
MK-biased HSCs that regulate HSC activity46 and the ﬁnding
that MK-secreted factors keep HSCs quiescent47, 48 raises the
intriguing possibility that MKs regulate the MK-biased pool
of HSCs.
These ﬁndings have immediate translational implications: On
the one hand, the vessel-biased MK distribution indicates, that
promoting megakaryopoiesis (e.g., by differentiation-promoting
chemokines) might be sufﬁcient to rapidly enhance platelet
production, as MKs do not need to migrate towards the
vasculature. On the other hand, the existence of two MK pools
(fast vs. more quiescent response) might explain why therapies to
increase platelet counts are not fully effective. We believe that
further studies addressing exactly this concept might ultimately
provide insights on how to activate the second quiescent MK pool
to accelerate platelet production.
Methods
Mice. All animal experiments were approved by the district government of Lower
Frankonia (Bezirksregierung Unterfranken). For all experiments, 8–12 week old
male and female mice (equal distribution in both groups) were used.
C57BL/6JRj mice were obtained from Janvier Labs. Mice lacking
talin1 speciﬁcally in MKs and platelets (Tlnﬂ/ﬂ, PF4-Cre; on a C57BL/6J background)
have been described previously32; Cre-negative litter mates served as control
animals. For the EdU treatment, each mouse (~30 g) was daily fed with 25 mg
EdU embedded in glucose-agarose cubes for 10 days prior to platelet depletion
and subsequently until the mice were euthanized. These experiments were
performed according to institutional guidelines by the district government of
Berlin, Germany.
Antibodies and reagents. Anesthetic drugs (medetomidine (Pﬁzer, Karlsruhe,
Germany), midazolam (Roche, Grenzach-Wyhlen, Germany) and fentanyl (Janssen
—Cilag, Neuss, Germany)) were used according to the local regulations. Mice were
bled in high-molecular-weight heparin (Ratiopharm, Ulm, Germany). Mice were
further treated with Plerixafor (AMD3100, Selleckchem, Munich, Germany; 5 mg/
kg bodyweight) or SRP4388 (SDF1 alpha, Sigma-Aldrich, Schnelldorf, Germany;
16 µg/kg bodyweight). Antibodies were ﬂuorescently labeled using protein labeling
kits (Alexa Fluor 488/546/594/647/750, Life Technologies, Darmstadt, Germany).
Anti-CD105 antibody (BioLegend, San Diego, CA, USA) or tetramethylrhodamine
dextran (2 MDa; Life Technologies, Darmstadt, Germany) were used for BM
vasculature staining. All other antibodies were generated and modiﬁed in our
laboratory as previously described19
Platelet depletion. Thrombocytopenia was induced in C57BL/6JRj WT mice by
intravenous injection of rat anti- GPIbα (CD42b; Emfret Analytics, Eibelstadt,
Germany; 2.0 μg/g body weight). Peripheral platelet counts were determined using
a fully automated hematology analyzer and additionally by ﬂow cytometry.
Cryo-sections. Femora and sterna of male and female mice age 8–12 weeks were
isolated, ﬁxed with 4% PFA (AppliChem GmbH, Darmstadt, Germany) (Appli-
Chem) in 5 mM sucrose in phosphate buffered saline (PBS), transferred into 10%
sucrose in PBS and dehydrated using a graded sucrose series (20%, 30%). Subse-
quently, the samples were embedded in SCEM medium (Section Lab,
Hiroshima, Japan), snap-frozen in liquid nitrogen and stored at −80 °C.
10 µm-thick cryosections were generated according to the Kawamoto protocol13
at a Leica CM1900 cryotom (Leica, Mannheim, Germany). For EdU-stainings,
sections were rehydrated 20 min with PBS followed by permeabilization for 30 min
with 0.5% Triton X-100. After three 5 min washes with washing buffer (PBS; 0.1%
Tween 20; 5% FCS), the click-it reaction was performed for 30 min according to the
manufacturer’s instructions (Click-iT® EdU Alexa Fluor® 647 Imaging Kit, Thermo
Fisher). MKs were stained with anti-CD41-FITC antibody (f.c. 5 µg/ml; Becton
Dickinson, Franklin Lakes, USA), anti-β1-tubulin antibody (f.c. 10 µg/ml;
Sigma-Aldrich, Schnelldorf, Germany), or anti-GPIX (f.c. 5 µg/ml; CD42a)
antibody. Secondary antibodies were purchased as conjugates with Alexa Fluor
488/594/647 (f.c. 7 µg/ml; Life Technologies, Darmstadt, Germany). Nuclei were
stained with Hoechst33258 (Biomol, Hamburg, Germany) and mounted with
Mowiol (Sigma-Aldrich) or 4′,6-diamidine-2′-phenylindole dihydrochloride
(DAPI)-containing mounting medium (DAPI Fluoromount-G; Southern Biotech,
Birmingham, AL, USA). Staining with antibodies and secondary reagents was
performed for 45 min at room temperature (RT). Sections were analyzed by con-
focal microscopy (Leica TCS-SP5) and processed with the Leica LAS AF software
and ImageJ software (NIH). MK number and density were measured in every
visual ﬁeld. Three femur sections from three separate animals were examined.
Megakaryocyte adhesion and proplatelet formation. Fetal liver cells of wildtype
mice were isolated from E14.5 old embryos and cultivated for 3 days at 37 °C and
5% CO2. Three hours prior to the enrichment of MKs via a bovine serum albumin
(BSA) gradient, the cells were incubated with IgG control antibodies (Emfret
Analytics, Eibelstadt, Germany), anti-α2-integrin (LEN/B49) or anti-GPIX deriva-
tives at 10 μg/mL or remained untreated. To determine proplatelet formation,
17,000 MKs/cm2 were seeded in triplicates and incubated at 37 °C and 5% CO2 for
24 h. For the adhesion assay 140,000 MKs were seeded on BSA or human ﬁbrillar
collagen I (Corning; 10 µg/cm2) coated coverslips (12 mm diameter) and incubated
for 4 h at 37 °C and 5% CO2. Afterwards the non-adherent cells were removed and
the adhered MKs were stained with an FITC conjugated anti-CD41 antibody (f.c. 5
µg/ml; Becton Dickinson, Franklin Lakes, USA) for 1 h before mounting them with
DAPI. At least 10 visual ﬁelds per cover slip were recorded at a TCS SP8 (Leica)
confocal microscope and the surface coverage analyzed with FIJI50.
Multiphoton intravital microscopy. Mice were anesthetized by intraperitoneal
injection of medetomidine 0.5 mg/g, midazolam 5 mg/g and fentanyl 0.05 mg/g
body weight. A 1-cm incision was made along the midline to expose the
frontoparietal skull, while carefully avoiding damage to the bone tissue. The mouse
was placed on a custom metal stage equipped with a stereotactic holder to
immobilize the head. BM vasculature was visualized by injection of tetra-
methylrhodamine dextran (8 µg/g body weight) and anti-CD105 Alexa Fluor 546/
Alexa Fluor 594 (0.4 µg/g body weight). Platelets and MKs were visualized by
injection of Alexa Fluor 488-labeled anti-GPIX derivative (0.6 µg/g body weight).
Images were acquired at a frame rate of 12 f/min or 1 f/min on an upright
two-photon ﬂuorescence microscope (TriM Scope I multiphoton system,
LaVision BioTec, Bielefeld, Germany or TCS SP8 MP, Leica Microsystems,
Wetzlar, Germany) equipped with a ×20 water objective with a numerical aperture
of 0.95. Emission was detected with HQ535/50-nm and ET605/70-nm ﬁlters.
A tunable broad-band Ti:Sa laser (Chameleon, Coherent, Dieburg, Germany)
was used at 760 nm to capture Alexa Fluor488 and Alexa Fluor 546/Alexa Fluor
594/tetramethylrhodamine dextran ﬂuorescence. FIJI50 and Imaris® 8.3.1 (Bitplane,
Zürich, Switzerland) were used to generate movies.
Tissue preparation for LSFM. Platelets/MKs and BM vasculature were stained by
injecting Alexa Fluor 750-labeled anti-GPIX derivative (0.6 µg/g body weight) and
anti-CD105 Alexa Fluor 647 (0.4 µg/g body weight), respectively. Thirty minutes
after injection the mice were transcardially perfused with ice-cold PBS to wash out
the blood and ice-cold 4% paraformaldehyde (PFA, Sigma-Aldrich, Schnelldorf,
Germany (pH 7.2)) to ﬁx the tissues. Sterna, skull, and femora were harvested and
stored in 4% PFA for 30 min. Bone samples were washed in PBS and decalciﬁed in
10% ethylenediaminetetraacetic acid (AppliChem, Darmstadt, Germany) for 96 h
at 4 °C on a shaker. Samples were then washed in PBS, followed by dehydration in
a graded methanol (Sigma-Aldrich) series (50%, 70%, 95%, 100% for 30 min each)
at RT and stored at 4 °C overnight. The methanol was replaced stepwise by a
clearing solution consisting of one part benzyl alcohol to two parts benzyl benzoate
(BABB, Sigma-Aldrich). After incubation in the clearing solution for at least 2 h at
RT, tissue specimens became optically transparent and were used for LSFM ima-
ging on the following day.
LSFM setup and data acquisition. Image acquisition of cleared samples was
performed in a home-built scanning light-sheet ﬂuorescence microscope similar to
previous designs18. The specimen was afﬁxed with cyanoacrylate glue (Weicon,
Münster, Germany) to a glass micropipette (100 µl, Brand GmbH) that was
mounted on a motorized (8CMA06-25/15 Standa, Vilnius, Lithuania) four axis
stage (xyz translation (Newport, Darmstadt, Germany) and rotation (Standa).
A home-built coverglass chamber ﬁlled with BABB solution allowed imaging of
the cleared sample immersed in clearing solution. A custom ﬁber coupled laser
combiner (BFI OPTiLAS GmbH, Groebenzell, Germany) with two red laser lines
(642 and 730 nm) was used for ﬂuorescence excitation. For collimation, an
objective lens (A10/0.25 Hund, Wetzlar, Germany) providing a beam diameter of
roughly 3 mm was used. All laser lines were joined via a dichroic beamsplitter
(DCLP 660, AHF Analysentechnik, Tübingen, Germany). A galvanometric scanner
(6210 H, Cambridge Technology, Bedford, MA, USA) elongated the resulting laser
beam with a frequency of 600 Hz before being focused via a theta lens (VISIR f.
TCS-MR II, Leica, Mannheim, Germany) to create a virtual light sheet. The focused
beam was relayed with a tube lens and an objective lens (EC Plan-Neoﬂuar 5x/0.16
M27, Zeiss, Göttingen, Germany) to the sample.
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For detection, a HCX APO L20x/0.95 IMM objective (Leica, Wetzlar, Germany)
was mounted on a translation stage (Newport) perpendicular to the light sheet. The
ﬂuorescence emission was spectrally ﬁltered using a motorized ﬁlter wheel
(MAC 6000 Filter Wheel Emission TV 60 C 1.0x (D)) with a MAC 6000 Controller
(Zeiss, Göttingen, Germany) equipped with the following ﬁlters according to the
ﬂuorescence of the used ﬂuorescent labels: 491 nm BrightLine HC 525/50
(autoﬂuorescence), 642 nm HQ 697/58 (Alexa Fluor 647), and 730 nm BrightLine
HC 785/62 (Alexa Fluor 750) (AHF). The image was generated by an inﬁnity-
corrected ×1.3 tube lens ∞/240–340 (098.9001.000, Leica, Wetzlar, Germany) and
detected by a sCMOS camera Neo 5.5 (2560 × 2160 pixels, 16.6 mm × 14.0 mm
sensor size, 6.5 µm pixel size, Andor, Belfast, UK). Synchronization of the laser
illumination, image acquisition, focus correction, and z scanning was controlled by
IQ 2.9 software (Andor). Multicolor stacks were generated by imaging the three
color channels sequentially in each plane in increments of 2 µm. Images were saved
as Tagged Image File Format (TIFF) stacks.
Image analysis. Multicolor LSFM stacks were processed and analyzed by FIJI50
and Imaris® 7.7.2 and 8.3.1 (Bitplane AG, Zurich, Switzerland). Data visualization
and analysis was performed in three major steps: (i) image preprocessing,
(ii) segmentation, (iii) data extraction. Step (i) was performed using either Imaris
or FIJI, steps (ii) and (iii) were performed using Imaris® 7.7.2 and 8.3.1 including
the ImarisCell module. Statistical analysis of object positions, numbers, and
volumes (MK, vessel, BM), edge-to-edge distance from MK to vessel or bone, and
available vessel interspace were performed using Microsoft Excel (ver. 2013,
Microsoft Corporation, Redmond, WA, USA), Origin (ver. 8.6, OriginLab
Corporation, Northampton, MA, USA), and SPSS Statistics (ver.23, IBM,
Ehningen, Germany) and Matlab software (Mathworks, USA). MKs were
considered to be vessel-associated MKs if the maximal distance between the MK
edge and the vessel was one voxel, where a voxel has the dimensions 0.5 × 0.5 × 2
µm3. All other MKs are referred as non-vessel-associated. Bone structures were
derived from autoﬂuorescence by using the pixel classiﬁcation algorithm of the
well-established interactive learning and segmentation toolkit ilastik51. Bone
structures derived from ilastik were exported to Imaris 8.3.1 for segmentation and
further analysis.
Multi-photon microscopy images were corrected for noise and converted to
binary images using FIJI. MKs that did release proplatelets during the observation
period were manually excluded prior to the cell tracking analysis. Cell tracking of
binary images was performed by Imaris 8.3.1 or with the active contours module of
Icy software (www.icy.bioimageanalysis.org, Institut Pasteur, France), where the
software calculated the center of mass of the cells from the binary images for each
frame. Mean square displacement analysis (MSD) of cell trajectories was performed
by using Matlab (Mathworks) and msdanalyzer class52. According to the diffusion
theory for two-dimensional data, the mean squared displacement is calculated for
different time scales and linked to these by
MSD ¼ 4Kαtα ð1Þ
where t is the time scale, Kα the time scale dependent diffusion coefﬁcient, and α
the exponential coefﬁcient of movement. While Kα lacks a distinct physical
meaning, exponent α deﬁnes different motion types as:
α= 1, for Brownian diffusion
α< 1, for subdiffusion or hindered diffusion
α> 1, for superdiffusion or enhanced diffusion
Computer simulations. Simulations were performed with a self-written algorithm
in Matlab software (Mathworks) using volume image stacks of mouse sterna
acquired by LSFM and processed with Bitplane Imaris® 7.7.2 software (see above).
For random simulation (SimR), MKs were randomly placed in the 3D BM space.
For NVA random simulation (SimNVA), BM vasculature and vessel associated
MKs served as space-limiting scaffold. The remaining MKs were randomly placed
into the intervascular region without vessel or cell contact. The MK-vessel distances
were calculated using vessel distance transformation maps. For both types of
simulations, the number and size distribution of MKs in the pool were matched to
the experimentally estimated values. The presented results are mean± SD from at
least three independent experiments per group, if not stated otherwise.
Statistical analysis. Differences between two groups were statistically analyzed
using the Mann–Whitney U test and difference between three or more groups
were analyzed using one-way ANOVA. P-values > 0.05 were considered as not
signiﬁcant (p > 0.05). P-values < 0.05 were considered statistically signiﬁcant with:
*p< 0.05, **p< 0.01, ***p < 0.001.
Data availability. The datasets generated and/or analyzed in the current study, as
well as the source code of the computational simulations are available from the
corresponding authors on reasonable request.
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